Ethinylestradiol and levonorgestrel preparations on the Belgian market: a comparative study
Vanheusden, V.; De Braekeleer, K.; Corthout, J.
Journal de Pharmacie de Belgique 1: 22-27
2012
ISSN/ISBN: 0047-2166 PMID: 22536680 Document Number: 659545
Preparations formulated as coated or film-coated tablets, containing levonorgestrel and the combination ethinylestradiol/levonorgestrel, were evaluated in a comparative study. This study comprised in vitro dissolution, assay and content uniformity. The analytical methods were previously validated according to international guidelines. All examined products complied with the postulated requirements.
Document emailed within 1 workday
Related Documents
Tantbirojn, P.; Taneepanichskul, S. 2002: Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women Contraception 66(6): 401-405Sanam, M.; Ziba, O. 2011: Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. which one has better affect on acne, hirsutism, and weight change Saudi Medical Journal 32(1): 23-26
Burness, C.B. 2015: Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): a Review of its use as an Oral Contraceptive Drugs 75(9): 1019-1026
Liu, C.Q.; Shen, S.R.; Dai, M.Z.; Zhu, J.Y.; Liu, G.M.; Li, L.Z. 1988: A comparative study on the antifertility action of levonorgestrel oxime and levonorgestrel Yao Xue Xue Bao 23(4): 252-257
Rákóczi, I.; Gerö, G.; Demeter, J.; Gáti, I. 1985: Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance Arzneimittel-Forschung 35(3): 630-633
Schwartz, U.; Hammerstein, J. 1973: The estrogenic potency of ethinylestradiol and mestranol--a comparative study Acta Endocrinologica. Supplementum 173: 118
Kahn, A. 1979: Unexpected and unexplained infant death. Epidemiologic and comparative study of Belgian and immigrant populations Archives Francaises de Pediatrie 36(7): 712-723
Endrikat, J.; Jaques, M.A.; Mayerhofer, M.; Pelissier, C.; Müller, U.; Düsterberg, B. 1995: A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance Contraception 52(4): 229-235
Matsumoto, S.; Sato, T.; Matsuyama, E.; Tamada, T.; Wagatsuma, T.; Honda, H. 1988: Results of a clinical study with low dose oral contraceptives investigation with triphasic and monophasic preparations containing levonorgestrel and ethynylestradiol Current Therapeutic Research 44(1): 165-177
Zhang, C.; Li, H.; Xiong, X.; Zhai, S.; Wei, Y.; Zhang, S.; Zhang, Y.; Xu, L.; Liu, L. 2017: An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch Drug Design Development and Therapy 11: 725-731
Elouni, B.; Ben Salem, C.; Zamy, M.; Ganne, N.; Beaugrand, M.; Bouraoui, K.; Biour, M. 2010: Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contraceptive use: 2 case reports Annals of PharmacoTherapy 44(12): 2035-2037
Omsjø, I.H.; Oian, P.; Maltau, J.M.; Osterud, B. 1989: Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis Acta Obstetricia et Gynecologica Scandinavica 68(1): 27-30
Edelman, A.; Munar, M.; Elman, M.R.; Koop, D.; Cherala, G. 2012: Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women British Journal of Clinical Pharmacology 74(3): 510-514
Kapitza, C.; Nosek, L.; Jensen, L.; Hartvig, H.; Jensen, C.B.; Flint, A. 2015: Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel Journal of Clinical Pharmacology 55(5): 497-504
Chabbert-Buffet, N.; Amy, J-Jacques. 2013: The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 18(2): 75-78
Cawello, W.; Rosenkranz, B.; Schmid, B.; Wierich, W. 2013: Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers Epilepsia 54(3): 530-536
Sabo, J.P.; Lang, B.; Elgadi, M.; Huang, F. 2015: Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers Antimicrobial Agents and ChemoTherapy 59(1): 514-519
Ågren, U.M.; Anttila, M.; Mäenpää-Liukko, K.; Rantala, M.-L.; Rautiainen, H.; Sommer, W.F.; Mommers, E. 2011: Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 458-467
Toivonen, J.; Luukkainen, T.; Allonen, H. 1991: Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstetrics and Gynecology 77(2): 261-264
Toivonen, J.; Luukkainen, T.; Allonen, H. 1991: Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstetrics and Gynecology 77(2): 261-264